Related Experiment Video
Updated: Jan 30, 2026

Primary Outcome Assessment in a Pig Model of Acute Myocardial Infarction
Published on: October 14, 2016
Acute Toxic Leukoencephalopathy: Etiologies, Imaging Findings, and Outcomes in 101 Patients
C Özütemiz1, S K Roshan2, N J Kroll3
1From the Department of Radiology (C.Ö., S.K.R., J.C.B., J.B.R., A.M.M.) ozutemiz@umn.edu.
Background And Purpose:
Prior studies regarding acute toxic leukoencephalopathy (ATL) are either small, or preliminary. Our aim was to evaluate etiologies of and differences in imaging severity and outcomes among various etiologies of ATL.
Materials And Methods:
MRIs of patients with suspected ATL over 15 years were retrospectively reviewed; inclusion criteria were: MRI <3 weeks of presentation with both DWI and FLAIR. These were jointly graded by two neuroradiologists via a previously described score of severity. Clinical outcome was evaluated via both modified Rankin (mRS) and ATL outcome (ATLOS) scores, each being correlated with the DWI and FLAIR scores. Etiologic subgroups of n > 6 patients were statistically compared.
Results:
Of 101 included patients, the 4 subgroups of n > 6 were the following: chemotherapy (n = 35), opiates (n = 19), acute hepatic encephalopathy (n = 14), and immunosuppressants (n = 11). Other causes (n = 22 total) notably included carbon monoxide (n = 3) metronidazole (n = 2), and uremia (n = 1). The mean DWI/FLAIR severity scores were 2.6/2.3, 3.3/3.3, 2.1/2.1 and 2.0/2.5 for chemotherapeutics, opiates, AHE and immunosuppressants, respectively, with significant differences in both imaging severity and outcome (P = .003-.032) among subgroups, particularly immunosuppressant versus chemotherapy-related ATL and immunosuppressants versus opiates (P = .004-.032) related ATL. DWI and FLAIR severity weakly correlated with outcome (ρ = 0.289-.349, P < .005) but correlated stronger in the chemotherapy (ρ = 0.460-.586, P < .010) and opiate (ρ =.472-.608, P < .05) subgroups, which had the worst outcomes. ATL clinically resolved in 36%, with severe outcomes in 23% (coma or death, 9/16 deaths from fludarabine). Notable laboratory results were elevated CSF myelin basic protein levels in 8/9 patients and serum blood urea nitrogen levels in 24/91.
Conclusions:
Clinical outcomes of ATL vary on the basis of etiology, being worse in chemotherapeutic- and opiate-related ATL. Uremia may be a predisposing or exacerbating factor.
Insights
Acute toxic leukoencephalopathy (ATL) outcomes vary by cause, with chemotherapy and opiate-related cases showing worse prognoses. Imaging severity weakly correlates with outcomes, but stronger in chemotherapy and opiate groups.
Area of Science:
- Neurology
- Radiology
- Toxicology
Background:
- Prior studies on acute toxic leukoencephalopathy (ATL) are limited in scope and preliminary.
- Understanding the diverse etiologies and their impact on imaging and clinical outcomes is crucial.
Purpose of the Study:
- To evaluate the various etiologies of acute toxic leukoencephalopathy (ATL).
- To compare differences in imaging severity and clinical outcomes across different ATL etiologies.
Main Methods:
- Retrospective review of 101 patients with suspected ATL over 15 years.
- Inclusion criteria: MRI within 3 weeks of presentation with DWI and FLAIR sequences.
- Imaging severity graded using a standardized score; clinical outcomes assessed via mRS and ATLOS scores; etiologic subgroups (n>6) statistically compared.
Main Results:
- Four main etiologic subgroups identified: chemotherapy (n=35), opiates (n=19), acute hepatic encephalopathy (n=14), and immunosuppressants (n=11).
- Significant differences in imaging severity and outcomes were observed among subgroups (P=.003-.032), with immunosuppressant-related ATL differing notably from chemotherapy and opiate-related ATL.
- Chemotherapy and opiate-related ATL subgroups showed the worst outcomes, with imaging severity weakly correlating to outcome overall, but stronger in these two groups.
Conclusions:
- Clinical outcomes of ATL are etiology-dependent, with poorer outcomes associated with chemotherapeutic and opiate exposure.
- Uremia may act as a predisposing or exacerbating factor in ATL.
- ATL resolved in 36% of patients, with 23% experiencing severe outcomes (coma or death).
More Related Videos
Related Concept Videos
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Predicting Reaction Outcomes
Finding the Center of Gravity
Outcomes of Glycolysis
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
Respiratory System Abnormal Finding I: Inspection and Percussion
Inspection Findings
During an inspection, several findings may suggest the presence of respiratory distress or disease. Pursed-lip breathing, where exhalation is slowed by...
Finding Electric Potential From Electric Field

